BodyGuardian Remote Monitoring System

by Boston Scientific Cardiac Diagnostics  · Based in United States → — Faster decisions. Proven accuracy. Better care.
Cardiology Pediatrics

Regulatory Status Disclosed

Overview

The BodyGuardian Remote Monitoring System is a non-invasive wearable device engineered to detect and monitor non-lethal cardiac arrhythmias in ambulatory patients. It continuously collects vital physiological data, including ECG, heart rate, respiration rate, and activity level, through a small, comfortable body sensor adhered to the patient’s chest. This data is then wirelessly transmitted via mobile phone technology to a secure, cloud-based platform (such as the Preventice Care Platform or ECG INSIGHT) for near real-time review by physicians, accessible online or through a dedicated mobile application.

The system integrates the capabilities of three essential monitoring technologies—mobile cardiac telemetry (MCT), event monitoring, and Holter monitoring—into a single, easy-to-use device, allowing clinicians to seamlessly switch between monitoring modes based on patient needs. It leverages sophisticated algorithms, including advanced BeatLogic deep learning AI, to accurately detect, classify, and interpret variations in heart rhythm data, thereby supporting timely diagnosis, improving physician efficiency, and facilitating proactive intervention. Developed in collaboration with Mayo Clinic, the BodyGuardian system is designed to provide robust data collection and offers a patient-centered design that is waterproof and allows for uninterrupted daily activities.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Wearable body sensor for continuous cardiac monitoring
  • Detects and monitors non-lethal cardiac arrhythmias
  • Collects ECG, heart rate, respiration rate, and activity level data
  • Combines mobile cardiac telemetry, event monitoring, and Holter monitoring in one device (e.g., BodyGuardian MINI PLUS)
  • Wireless data transmission via mobile phone to a cloud-based platform
  • Physician review via web portal or dedicated mobile application (e.g., iPad app)
  • Sophisticated algorithms, including BeatLogic deep learning AI for accurate rhythm analysis
  • Waterproof and comfortable design for uninterrupted daily activities
  • Electronic Medical Record (EMR) integrations
  • Approved for both adult and pediatric use (BodyGuardian MINI PLUS)

Use Cases

  • Remote monitoring of cardiac arrhythmias in ambulatory patients
  • Diagnosis of irregular heartbeats (e.g., Atrial Fibrillation, tachycardia, bradycardia)
  • Post-procedure cardiac monitoring
  • Long-term cardiac monitoring (e.g., beyond 30 days)
  • Reducing hospitalizations and re-admissions through timely insights
  • Improving physician efficiency and facilitating timely intervention

What Physicians Need to Know

ECG/EKG Analysis Capability
The BodyGuardian Remote Monitoring System records and analyzes ECG data to detect and monitor cardiac arrhythmias. It provides high-fidelity arrhythmia detection and offers accurate, high-quality ECG monitoring across various modalities, including Holter, Connected Holter, and Mobile Cardiac Telemetry (MCT).
Echocardiography AI Features
The BodyGuardian system, along with the PatientCare platform, offers near real-time analysis of ambulatory echocardiogram data designed to support clinical diagnosis and outcomes.
Cardiac CT/MRI Analysis
The BodyGuardian Remote Monitoring System monitor cannot be worn while undergoing an MRI or a surgical procedure.
Arrhythmia Detection Accuracy
The system delivers 99% final report accuracy, powered by BeatLogic™ and ECG Insight™. The BeatLogic AI algorithm automates beat and rhythm detection for 34 rhythm classifications, leveraging deep-learning ECG analysis built on large, real-world datasets. BeatLogic has a beat detection sensitivity of >99%, sinus sensitivity of >97%, VT sensitivity of >97%, and AFib sensitivity of >96%.
Heart Failure Risk Prediction
While the BodyGuardian system focuses on arrhythmia detection, Boston Scientific also offers the HeartLogic™ Heart Failure Diagnostic in their implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems, which has shown 70% sensitivity in detecting heart failure events several weeks in advance. This separate system continuously receives data from the heart by evaluating heart sounds, respiration rate and volume, thoracic impedance, heart rate, and activity to determine elevated risk of heart failure.
Cardiac Monitoring Integration
The BodyGuardian system integrates seamlessly with various systems to reduce setup and administrative burden. It offers robust data collection and a wide range of electronic medical record (EMR) integrations, including Cardiovascular Information System (CVIS) and Cardiovascular Implantable Electronic Device (CIED) integrations. Boston Scientific provides configurable EMR integration options, dedicated local EMR integration experts, and has over 15 years of integration experience with 1,300+ sites live with EMR integration. Integrations follow HIPAA, HITECH, SOC2, Security (encryption, visibility, scalability), and HL7 Interchange guidelines.
AHA/ACC Guideline Alignment
The BodyGuardian MINI and MINI PLUS cardiac monitors are FDA approved for their labeled indications. The system is intended to assist healthcare professionals in evaluating a patient's cardiac health, with reports generated for clinician review.
Real-Time Alert Capability
For the BodyGuardian MINI PLUS in cardiac event monitoring mode, heart data is transmitted in near real-time to Boston Scientific Cardiac Diagnostics' monitoring center. In MCT and Event mode, the system offers near real-time monitoring and urgent arrhythmia detection for rapid clinical response. The BeatLogic AI algorithm delivers timely reports and critical notifications. When a potentially serious heart abnormality is detected, the physician is notified.
Physician Tip

The BodyGuardian Remote Monitoring System is designed to provide high-fidelity arrhythmia detection and accurate ECG analysis, aiding in timely diagnosis and treatment planning. The BeatLogic AI algorithm, with its deep-learning capabilities and 34 rhythm classifications, enhances diagnostic confidence and reduces false positives. The system's seamless integration with EMR platforms can streamline workflows and reduce administrative burden. For patients requiring continuous, near real-time monitoring, the BodyGuardian MINI PLUS offers urgent arrhythmia detection and rapid clinical response. It's important to remember that the system assists in monitoring and does not provide direct diagnosis; interpretation of ECG data remains the responsibility of the supervising physician. The device is contraindicated for patients requiring attended, in-hospital monitoring for life-threatening arrhythmias or for detection of hemodynamically unstable or life-threatening cardiac events requiring urgent medical response.

The BodyGuardian Remote Monitoring System offers robust integration capabilities with leading EMR platforms, including CVIS and CIED systems. Boston Scientific provides configurable integration options, dedicated support from local EMR integration experts, and has extensive experience in this area. Integrations adhere to HIPAA, HITECH, SOC2, Security (encryption, visibility, scalability), and HL7 Interchange guidelines, ensuring secure and compliant data exchange. The system supports discrete data elements (DDE) integration via orders and results interface, and raw data via Application Program Interface (API).

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Unknown
DeploymentCloud-based platform with EMR integration.
Mobile App1
API AvailableUnknown
Data ExportUnknown
TrainingUnknown
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Pediatrics

Support & Reliability

Training ProvidedUnknown

What the Web Says

The BodyGuardian Remote Monitoring System by Boston Scientific is an AI-enabled device designed to detect and monitor cardiac arrhythmias in ambulatory patients. It transmits ECG data from various settings for clinician review. The system aims to be unobtrusive and easy for patients to use, automatically uploading data without requiring patient interaction.

Overall: Positive

Strengths

  • AI-enabled for enhanced detection and monitoring of cardiac arrhythmias.
  • Transmits ECG data from both clinical and non-clinical settings.
  • Unobtrusive and comfortable for patients to wear, promoting compliance.
  • Automatic data upload, simplifying use for patients.
  • High quality ECG signal and consistent ECG morphology.
  • Combines ECG, heart rate, respiratory rate, and activity levels for comprehensive data.

Limitations

  • Not intended for patients requiring in-hospital monitoring for life-threatening arrhythmias.
  • Does not provide diagnosis; reports are for clinician review and confirmation.
  • Not for use in detecting or notifying hemodynamically unstable or life-threatening cardiac events requiring urgent medical response.
  • HealthAIdir lists it as a conditional seed profile pending deeper vendor evidence review.

Based on reviews from: healthaidir.com, coherentmarketinsights.com, cardiovascularbusiness.com, hmpgloballearningnetwork.com, fda.gov

Last updated: 2026-10-31

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate BodyGuardian Remote Monitoring System

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Coherent Market Insights
FDA Clears Boston Scientific's BodyGuardian Remote Monitoring System
In January 2026, the FDA cleared Boston Scientific's BodyGuardian Remote Monitoring System for detecting and monitoring cardiac arrhythmias in ambulatory patients, transmitting ECG data from various settings. The system incorporates BeatLogic AI for beat, rhythm, and waveform classification under clinician review.
2026-01
MassDevice
Boston Scientific Highlights AI-Guided Heart Rhythm Adjudication Accuracy
A new analysis from Boston Scientific in April 2025 indicated that AI-guided heart rhythm adjudication, part of the BodyGuardian remote monitoring system, was as accurate as expert electrophysiologists in classifying atrial arrhythmias, potentially reducing labor costs.
2025-04
MarketScale
AI in Cardiology: BodyGuardian Remote Monitoring System (BGRMS v3.0) Noted in June 2026 Cardiology Clearance List
Boston Scientific's BodyGuardian Remote Monitoring System (BGRMS v3.0) was included in Cardiovascular Business's June 2026 cardiology clearance list, highlighting its use of AI for arrhythmia detection and monitoring.
2026-09
FDA
FDA Clears BodyGuardian Remote Monitoring System (BGRMS v3.0)
On January 23, 2026, the FDA cleared the BodyGuardian Remote Monitoring System for use with adult and pediatric patients (at least 29 days old) in clinical and non-clinical settings to collect and transmit ECG and other health parameters.
2026-01
Cardiovascular Business
Cardiology Remains No. 2 in FDA-Cleared AI Models, Including BodyGuardian RMS
As of June 2026, the FDA had cleared 225 AI algorithms for cardiology, with Boston Scientific's BodyGuardian Remote Monitoring System (BGRMS v3.0) listed among them for detecting and monitoring cardiac arrhythmias in ambulatory patients.
2026-06
FDA
BodyGuardian Remote Monitoring System (BGRMS v3.0) Listed by FDA
The FDA listed the BodyGuardian Remote Monitoring System (BGRMS v3.0) from Boston Scientific Cardiac Diagnostic Technologies, Inc. in October 2026, with Meghan Styles as the applicant contact.
2026-10
Roots Analysis
Regulatory Momentum for Cardiac RPM: BodyGuardian System Clearance Noted
FDA documentation in January 2026 showed clearance for Boston Scientific Cardiac Diagnostic Technologies' BodyGuardian Remote Monitoring System for ambulatory arrhythmia detection and monitoring, supporting physician confidence in extended outpatient monitoring.
2026-01
Cardiovascular Business
BodyGuardian Remote Monitoring System Uses AI for Arrhythmia Detection
The Boston Scientific BodyGuardian Remote Monitoring System utilizes AI to assist in the detection and monitoring of cardiac arrhythmias, placing cardiology as the second-highest specialty for AI approvals.
2026-07

Videos

Product demos, reviews, and walkthroughs for BodyGuardian Remote Monitoring System.

Loading videos...

View all on YouTube

Frequently Asked Questions

The BodyGuardian Remote Monitoring System is designed to detect and monitor cardiac arrhythmias in ambulatory patients. It collects and transmits electrocardiogram (ECG) and other health parameters to healthcare professionals for monitoring and evaluation.
The BodyGuardian Remote Monitoring System utilizes AI algorithms, specifically the BeatLogic™ AI algorithm, to help detect and monitor cardiac arrhythmias. This AI automates ECG interpretation, flags out-of-range values, and provides accurate rhythm interpretation, enhancing clinical decision support.
The BodyGuardian Remote Monitoring System does not provide a direct diagnosis; a supervising physician is responsible for ECG data interpretation. It is contraindicated for patients requiring attended, in-hospital monitoring for life-threatening arrhythmias or for the detection of hemodynamically unstable or life-threatening cardiac events requiring urgent medical response. It is also not suitable for use in an MRI environment or with high-frequency surgical equipment or external defibrillators.
While the BodyGuardian system offers comprehensive cardiac monitoring, other remote cardiac monitoring devices include implantable devices like pacemakers and ICDs, wearable devices such as ECG patches (e.g., Zio ECG patches) and smart shirts (e.g., Hexoskin Medical System), and physiological monitors like blood pressure cuffs. Other companies offering remote patient monitoring solutions include Medtronic, Philips, and Optimize Health.
The BodyGuardian monitors are designed to be patient-centered, featuring a fully waterproof and submersible design, multiple adhesive and placement options, and a long battery life to support patient comfort and compliance. Patients can maintain their daily activities, including showering and swimming, without disrupting monitoring.
The BodyGuardian MINI and MINI PLUS support various monitoring modalities, including Mobile Cardiac Telemetry (MCT), Connected Holter, and Holter. These options allow for continuous monitoring for up to 30 days, with near real-time transmission for urgent arrhythmia detection in MCT mode, which can improve diagnostic accuracy, especially for intermittent arrhythmias like AFib.
The BodyGuardian system is designed for workflow simplicity, integrating seamlessly with existing systems and offering robust data collection with a wide range of electronic medical record (EMR) integrations. Boston Scientific's cardiac monitoring device portfolio integrates with Epic Aura, allowing providers to submit orders, receive results, and review reports directly within Epic.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-04-19 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.